Eleven rocaglamide derivatives (cyclopentatetrahydrobenzofurans) and one structurally related aglain congener all isolated from different Aglaia species (Meliaceae) were tested for growth inhibiting properties using the human cancer cell lines MONO-MAC-6 and MEL-JUSO. Proliferation of both cell lines was efficiently inhibited in a dose and compound de pendent manner. Applying a MTT-Assay, the IC50 of the most active compound didesmethylrocaglamide (1) was observed at 0.002 and 0.006 [ig/ml (0.004 and 0.013 j.iM) depending on the cell line investigated. Bulky aminoacyl substituents at C-2, acetylation of the OH substitu ent at C-l or insertion of a OH or OMe substituent at C-3 of the rocaglamide skeleton all diminished the activity of the compounds investigated. The aglain derivative 12 was inactive up to a concentration of 3 ng/ml (4.6 [ . i m ) . This loss of activity is assumed to be mainly due to the presence of a pyran ring in the aglains vs. a furan ring as found in rocaglamide derivatives. Rocaglamide derivatives may act primarily by inhibition of cell proliferation as evidenced by the absence of a significant cytotoxic effect in long-term cultures of MONO-MAC-6 cells treated with high doses of didesmethylrocaglamide.
Introduction
The genus Aglaia (M eliaceae) consists of ap proximately 130 species that are dioecious trees or shrubs with small fragrant flowers (Li, 1977; R id ley, 1922) . Species of Aglaia form an im portant el ement of moist tropical forests in the Indo-Malaysian region (Pannel, 1992) . Several species, such as A. odorata, are traditionally used in folk medicine in South-East Asia for example as a heart stimu lant, as febrifuge, for the treatm ent of coughs, in flammations or injuries (Kokpol et al., 1994) . O ther Aglaia species including A. duperreana are widely cultivated in Vietnam, China and in parts of Indo-Malaysia for their fragrant flowers which are used for scenting tea.
Phytochemically Aglaia species are charac terized by the accumulation of cyclopentatetrahydrobenzofurans (1 ) also known as rocaglamide de rivatives (Nugroho et al., 1997a; Nugroho et al., 1997b; Giissregen et al., 1997; D um ontet et al., 1996; Ewete et al., 1996; Ishibashi et al., 1993; Janprasert et al., 1993; King et al.,1982) . Rocaglamide derivatives are powerful natural insecticides which are comparable, with regard to their insecticidal activity, to the well known natural insecticide azadirachtin isolated from the neem tree A zadirachta indica (Nugroho et al., 1997a; Ewete et cd., 1996) . Recently, a pronounced antiproliferative ac tivity of certain rocaglamide derivatives against human cancer cells was reported (Cui et al., 1997; Wu et al., 1997) prompting us to conduct a com parative study on the cytotoxic activity of eleven naturally occurring rocaglamide derivatives 1-11 and of one closely related aglain derivative 12 using two human cancer cell lines derived from monocytic leukemia and melanoma. Here we re port on the structure-activity relations of antipro liferative rocaglamide derivatives.
Materials and Methods

Plant material
Flowers and stems of Aglaia duperreana were collected in Vietnam (near Ho Chi Minh City) in April 1995 and January 1998 and were specified by one of us (L. C. K., Dept, of Botany, University HCMC). Flowers of Aglaia odorata and seeds of Aglaia elliptica were supplied in December 1994 by the Botanic G arden at Bogor, Indonesia. Voucher specimens are on file in the J.-v.-SachsInstitut für Biowissenschaften, Universität Würzburg.
Isolation o f the rocaglamide derivatives
The isolation and structural elucidation of the rocaglamide derivatives with complete data of MS, 'H -and 13C-, 2D-NMR. CD and optical rotation were previously described (Nugroho et al., 1997a; Nugroho et al., 1997b; Güssregen et al., 1997) . D e tailed spectroscopic data of the aglain derivative 12 are published separately elsewhere (Nugroho, 1998) .
Chemicals
MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazoliumbromide] was purchased from Sigma (Deisenhofen, Germany). RPMI 1640-Cell culture medium and supplements, fetal bovine serum (FBS). penicillin and streptomycin were obtained from Gibco-BRL (Eggenstein, Germany). EG M M E (ethylene glycol monomethyl ether) was from Merck (Darm stadt, Germany).
Proliferation assays
The rocaglamide derivatives and the aglain de rivative were tested for their cytotoxic activity against the two human cancer cell lines MONO-MAC-6 ( The cells were grown in plastic flasks (Nunc, Wiesbaden, Germany). All cultures were propa gated using standardized media supplemented with 1 0 -2 0 % heat-inactivated fetal bovine serum and were cultivated at 37 °C in a humidified atm o sphere containing 5% C 0 2. Details are outlined in the DSMZ Catalogue of Hum an and Animal Cell Lines (D rexler et al., 1997).
The freeze-dried rocaglamides were dissolved in EGM M E (ethylene glycol monomethyl ether), di luted in RPMI-1640 culture medium and stored frozen at -2 0 °C. At the final dilution used in the experiments, the EGM M E concentration was 0.1%.
For the experiments, exponentially growing cells (viability of >90% as m easured by trypan blue ex clusion) were harvested, washed and resuspended in fresh medium at a final concentration ranging between 2 and 4 x 105 cells/ml (depending on the cell line). Total cell num ber and viability were de termined in a cell counting cham ber after staining the cells with trypan blue. Aliquots of 90 [il were seeded out into 96-well flat-bottom culture plates (Nunc, W iesbaden, Germ any). Ten microliters with medium, medium with the solvent EGM M E or the different concentrations of the rocaglamide derivatives were added. A fter a 48 h incubation/ cultivation period the extent of cytotoxicity was evaluated by the MTT assay as described recently (Steube et al., 1998) .
All experim ents were carried out in triplicates and repeated three times. As controls, media with 0.1% EG M M E were included in the experiments. To avoid bacterial contam ination all experiments were carried out in the presence of 100 IU/ml pen icillin G and 100 j-ig/ml streptomycin.
Results and Discussion
The antiproliferative activity of rocaglamide de rivatives 1-11 as well as of the structurally related aglain derivative 12 was investigated using two hu man cancer cell lines M ONO-M AC-6 and MEL-JUSO that are firmly established in anti-cancer re search. M ONO-M AC-6 grows as suspension cul ture and is derived from a monocytic leukemia representing typical features of monocytic cells (Ziegler-Heitbrock et al., 1988) and is widely used as model systems in hematology and immunology (Steube and Drexler, 1995) solid tum or mass of a melanoma (Johnson et al., 1981) .
The rationale for studying a series of rocaglam ide derivatives 1 -1 1 for their antiproliferative ef fect was based on the known structural diversity of naturally occurring rocaglamides that usually differ from each other by the nature of their sub stituents at C-l (-OH vs. -OAC), C-2 (different amino acyl substituents vs. -C O O C H 3 group) and/ or C-3 (-H vs. -OH or -OCH3) whereas the substi tution pattern at the remaining carbons of the ro caglamide skeleton as well as the absolute configu ration of the various congeners are remarkably stable (Nugroho et al., 1997a; Nugroho et al., 1997b; Gtissregen et al., 1997) . Only didesmethylrocaglamide (1) and rocaglamide (3) had been tested earlier (D um ontet et al., 1996; Wu et al., 1997) whereas the cytotoxic activity of the rem ain ing compounds is reported here for the first time. The aglain derivative 12 that sometimes cooccurs together with rocaglamide-type compounds, as for example in A. odorata (Nugroho, 1998) , was in cluded into the bioassays since it is structurally re lated to rocaglamide (3) and its congeners but dif fers from the latter by the nature of its heterocycle which is a pyran ring in 12 compared to a furan ring in 1-11, as well as by the size of the aminoacyl substituent.
All of the compounds studied except the aglain derivative 12 exhibited pronounced antiprolifera tive activity against the two cell lines in the MTTassay (Table I ). The IC50 of didesmethylrocaglamide (1 ) which turned out to be the most active compound detected in this study was 0.002 and 0.006 |ig/ml (corresponding to 0.004 and 0.013 jim) for M ONO-M AC-6 and MEL-JUSO, respectively and is thus comparable to that of the wellknown anticancer drug vinblastine sulfate (Table I) . R e placement of the CONH2 substituent at C-2 by a larger aminoacyl substituent as in compounds 3 or 4 caused a slight but noticeable and reproducible decrease in inhibitory activity (between two-to eightfold) compared to didesmethylrocaglamide A further decrease of antiproliferative activity was observed when C-3 was substituted by an OH-group as in compounds 5 -7 . For example, whereas the IC50 of didesmethylrocaglamide (1 ) was 0.002 ^ig/ml (0.004 ^im) for M ONO-M AC-6 cells this value increased to 0.018 [.ig/ml (0.037 ^im) for compound 5 which is the 3 -OH analogue of 1. A similar result was obtained when the com pounds were tested in M EL-JUSO cells (Table I) . Acetylation of the OH-substituent at C-l as in compounds 8 and 11 resulted in an approximately twofold loss of activity as compared to the corre sponding deacetyl congeners 6 and 7: the IC50 of compound 6 for M ONO-M AC-6 cells was 0.053 [ig/ml (0.105 ^im), the IC50 of the acetylated congener 11 amounted to merely 0.103 [ig/ml (0.188 (im ) . A similar trend with regard to the bio activity of acetylated vs. deacetylated rocaglamide derivatives was observed when testing MEL-JUSO cells.
Replacement of the amino acyl substituent of the rocaglamide derivatives 5 -7 by an esterified acyl group as in compound 10 resulted in a decrease of the antiproliferative activity in both cell lines tested as evident from inspection of the IC50 values of compounds 5 -7 compared to 10 ( Table I ).
The aglain derivative 12 which differs from the rocaglamide congeners 1-11 by presence of a pyran vs. a furan ring and by a larger aminoacyl side chain was completely inactive in both cell lines even when tested at concentrations as high as 3 (j,g/ ml (4.6 |im ) which is roughly 20-30 times higher than the IC50 values of the weakest rocaglamide derivatives 10 or 11 encountered during this study (Table I) . It may be assumed that the dramatic loss of activity of 12 observed in this study is rather due to the replacem ent of the furan ring of the rocaglamide derivatives by the pyran ring of the aglain derivative 12 than by the bulky aminoacyl substituent of 12. The size of the amino acyl side chain at C-2 has a small but significant influence on the degree of antiproliferative activity of the various rocaglamide derivatives investigated as ev idenced by the IC50 values of compounds 1 -4 , im plying a small substituent as beneficial for antipro liferative activity. However, a total loss of activity as experienced for compound 12 is probably not attributed to this structural feature alone. Apply ing a second proliferation assay, the incorporation of [3H]-thymidine for several selected rocaglamide derivatives, confirmed the results obtained by the MTT-test (data not shown).
It is interesting to note that the structure activity relationships of compounds 1 -1 2 analyzed in this study (Table I) are largely paralleled by their dif ferent degree of insecticidal activity which was re ported earlier using larvae of the polyphagous pest insect Spodoptera littoralis (Nugroho, 1998 ; Nugroho et al., 1997a; Nugroho et al., 1997b; Giissregen et a l, 1997). It is therefore most likely that the hitherto unknown target(s) of rocaglam ide derivatives in human cancer cells are similar or identical to the targets present in insects.
In a further set of experiments the survival-rate of M ONO -M AC-6 cells was determ ined after a 48 h exposure to different concentrations of didesmethylrocaglamide (1 ), which represents the most active com pound encountered in this study (Fig. 3) . A fter an initial exposure of the cells to didesmethylrocaglamide (1) for 48 h the cells were washed and transferred to control medium (with 0.1% EG M M E but without compound (1)) for subsequent 48 h. The concentrations of compound 1 applied for this experim ent (0.020, 0.050 and 0.100 |.ig/ml) were by far beyond the determined IC50 value of 0.002 [ig/ml. Even at these exceed ingly high concentrations only an insignificant num ber of cells died during the first 48 h of the experim ent as indicated by a constant num ber of viable cells (Fig. 3) . Following transfer into fresh medium without compound 1 the number of viable cells in the culture, which had been treated with the lowest concentration of 1 (0.020 [ig/ml) re mained almost constant whereas the viable cell num bers of the cultures which had been pre treated with 0.050 or 0.100 [xg/ml of compound 1 decreased slightly (Fig. 3) . This experiment indi cated that didesmethylrocaglamide (1 ) (and prob ably also the other rocaglamide derivatives) clearly inhibits cell proliferation but is only sligthly toxic to M ONO-M AC-6 cells even at concentra tions that are 25-50 times higher than its IC50 of 1 as determ ined by the MTT assay (Table I ). The experim ent indicated furthermore that the anti proliferative effect of compound 1 can not easily be neutralized by transferring the exposed M ONO -M AC-6 cells into fresh medium since the cell num bers did not increase from 48-96 h following onset of the experiment (Fig. 3) . It is possible that compound 1 which is rather lipo philic, enters the cells, binds to an unknown target (thereby suppressing cell proliferation) and could not be liberated from its intracellular target by washing the treated cells and subsequent culture in norm al medium. Since these compounds may be interesting candidates for anti-cancer research, further research on the mode of action of antipro liferative rocaglamide derivatives is required.
In Vietnam as well as in other South East Asian countries the fragrant flowers of A. duperreana or of A. odorata are commonly added to tea thereby m aking a popular drink that is consumed daily by large parts of the population on a regular basis (Perry and Metzger, 1980) . Flowers from both Aglaia species are known to contain rocaglamide de rivatives. Even though these compounds are rather lipophilic in nature they are extractable in hot water and can be detected in a typical herbal tea using HPLC analysis (Bohnenstengel et al., unpublished results). We treated three purified rocaglamide de rivatives, compounds 1 -3 , with boiling water and proved that these compounds are stable and not subject to heat-induced chemical alterations. Even though no effort was made so far to determ ine the actual concentrations of rocaglamide derivatives present in a typical tea scented with Aglaia flowers it is conceivable that trace amounts of these com pounds are incorporated on a regular basis over many years. The fate of ingested rocaglamide deriv atives in humans (e.g. resorption, pharm acokinet ics, metabolism) is completely unknown. Due to the potential antiproliferative activity of rocaglamide derivatives and in view of the regular and pro longed exposure of a considerable part of the South East Asian population to rocaglamides, these com pounds represent interesting subjects for further studies.
